Suchergebnisse - "COVID-19 Vaccines"

PubPharm (5.019)

91

Fourth dose of microneedle array patch of SARS-CoV-2 S1 protein subunit vaccine elicits robust long-lasting humoral responses in mice

enthalten in: International immunopharmacology | 2024

von Kim, E. | Shin, J. | Ferrari, A. | +9

92

Safety and neutralization antibody levels of inactivated SARS-CoV-2 vaccine in adult patients with Myasthenia Gravis : a prospective observational cohort study

enthalten in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology | 2024

von Zheng, W. | Cao, X. | Luo, J. | +6

93

Mass spectrometry study on SARS-CoV-2 recombinant vaccine with comprehensive separation techniques to characterize complex heterogeneity

enthalten in: Analytica chimica acta | 2024

von Wu, G. | Du, J. | Yu, C. | +4

94

The Nucleocapsid Protein of SARS-CoV-2, Combined with ODN-39M, Is a Potential Component for an Intranasal Bivalent Vaccine with Broader Functionality

enthalten in: Viruses | 2024

von Lobaina, Y. | Chen, R. | Suzarte, E. | +11

95

Single MVA-SARS-2-ST/N Vaccination Rapidly Protects K18-hACE2 Mice against a Lethal SARS-CoV-2 Challenge Infection

enthalten in: Viruses | 2024

von Clever, S. | Limpinsel, L. | Meyer Zu Natrup, C. | +13

96

Reactogenicity and Peak Anti-RBD-S1 IgG Concentrations in Individuals with No Prior COVID-19 Infection Vaccinated with Different SARS-CoV-2 Vaccines

enthalten in: Laboratory medicine | 2024

von Milevoj Kopcinovic, L. | Unic, A. | Nikolac Gabaj, N. | +4

97

25-Hydroxyvitamin D concentrations do not affect the humoral or cellular immune response following SARS-CoV-2 mRNA vaccinations

enthalten in: Vaccine | 2024

von Lavell, A. | Schramade, A. | Sikkens, J. | +35

98

Risk of SARS-CoV-2 breakthrough infection following NVX-CoV2373 and BNT162b2 vaccinations in Korean Adults : A population-based observational study

enthalten in: Vaccine | 2024

von Kim, H. | Park, S. | Choe, S. | +10

99

Vaccine effectiveness against COVID-19 : A test negative case-control study in Tunisia, August 2021

enthalten in: Vaccine | 2024

von Mziou, E. | Hchaichi, A. | Letaief, H. | +10

100

Immunogenicity and safety of a SARS-CoV-2 mRNA vaccine (SYS6006) in healthy Chinese participants : A randomized, observer-blinded, placebo-controlled phase 2 clinical trial

enthalten in: Vaccine | 2024

von Jin, F. | Qiu, Y. | Wu, Z. | +21